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Natural killer (NK) cells are essential for the early control of murine cytomegalovirus (MCMV) infection.
Here, we demonstrate that toll-like receptor 2 (TLR2) plays a role in the NK cell-mediated control of MCMV.
TLR2 knockout (KO) mice had elevated levels of MCMV in the spleen and liver on day 4 postinfection
compared to C57BL/6 mice. In vivo depletion of NK cells with anti-NK1.1 antibodies, however, eliminated the
differences in viral titers between the two groups, suggesting that the effect of TLR2 on MCMV clearance on
day 4 was NK cell mediated. The defect in early antiviral control was associated with a decreased NK cell
population in the spleen and liver and reduced amounts of interleukin-18 and / interferon secreted in the
TLR2 KO mice. Our studies suggest that in addition to the reported involvement of TLR9 and TLR3, TLR2
is also involved in innate immune responses to MCMV infection.
NK cells play a crucial role in the early phase of murine
cytomegalovirus (MCMV) infection in mice. It was demon-
strated decades ago that natural killer (NK) cell depletion
decreased resistance to MCMV, and mouse mutants with im-
paired NK cell function (such as beige mice) had high suscep-
tibility (48, 41). Moreover, young mice that lacked fully devel-
oped NK cell responses succumbed to MCMV infection, but
the transfer of mature NK cells prevented a fatal outcome in
these young hosts (10).
The activation, proliferation, trafficking, and effector func-
tions of NK cells in response to MCMV infection are regulated
by complex pathways. Multiple mechanisms are utilized to
activate NK cells in response to the virus. In C57BL/6 mice, the
viral gene product gp m157 serves as a ligand for the activating
NK receptor Ly49H (4, 43), and this interaction contributes to
the induction of NK cytotoxicity directed against virus-infected
targets. Ly49H is now considered the product of the Cmv-1
locus, a genetic determinant of MCMV resistance located in
the NK gene complex on chromosome 6 (9, 16, 28, 29, 42, 43).
Ly49H is the first confirmed example of a positively signaling
mouse NK receptor that can specifically recognize a viral gene
product. Cytokines secreted by dendritic cells (DC) and mac-
rophages activated by the infection also make a large contri-
bution to NK cell activation. / interferon (IFN-/), long
known to be an NK cell activator (50), has recently been shown
to be secreted by Ly6 G/C plasmacytoid DC after MCMV
infection (15). IFN-/ and interleukin-15 (IL-15) promote
NK cell proliferation and survival, whereas IL-12 and IL-18
augment the secretion of IFN- by NK cells (33, 36). More
recently, roles for IL-12 and IL-18 in the expansion of the NK
cell population were demonstrated (3).
The kinetics of the expansion of the NK cell population after
systemic MCMV infection is well characterized. In the spleens,
the number of NK cells shows a transient decrease on day 2
postinfection, followed by an increase that reaches peak num-
bers by day 6 (16). A recent study pointed out the essential role
of the CD8 CD11c splenic DC in the expansion of the NK
cell population, and a complex relationship between these DC
and Ly49H NK cells was suggested. The presence of Ly49H
NK cells was associated with low virus titers and promoted the
survival of the CD8 CD11c DC population in the spleen.
In turn, these DC seemed to be required for the subsequent
expansion of Ly49H NK cells, and this process was depen-
dent on cytokines, mostly IL-18 (3, 16).
In spite of extensive research on the MCMV model, the
mechanisms involved in the initial detection of MCMV infec-
tion by cells of the innate immune system (e.g., DC and mac-
rophages) are not completely understood, and the possible role
of innate receptors in this process has just recently started to
be addressed. Toll-like receptors (TLRs) are transmembrane
proteins that function as microbial pattern recognition mole-
cules (1, 51). Common features of TLRs are the leucine-rich
extracellular domain and the intracellular signaling motif called
the Toll/IL-1 receptor domain (39). The activation of TLRs by
pathogen-associated molecular patterns leads to a rapid innate
immune response and also orchestrates the induction of the ap-
propriate adaptive immune responses (1, 5, 35, 39, 45, 51). Ini-
tially, only molecules of bacterial and fungal origin were regarded
as TLR-activating ligands. Recently, however, it has become clear
that virus infections are also detected by TLRs. Intracellular mo-
lecular signatures of virus infection (such as double-stranded
RNA, CpG DNA motifs in viral genomes, or single-stranded viral
RNA sequences) function as TLR activators (2, 17, 19, 31), as
some TLRs are situated inside cells, not on the cell membranes.
Several examples of TLR-activating viral proteins have also been
reported, although it is not known what pathogen-associated mo-
lecular patterns are displayed on viral proteins. Innate immune
responses to the fusion protein of respiratory syncytial virus
(RSV) were shown to be mediated by TLR4 (18, 26). Cytokine
responses to human CMV (HCMV), herpes simplex virus type 1
(HSV-1), and mouse mammary tumor virus (MMTV) envelope
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proteins and measles virus hemagglutinin are mediated by TLR2
(6, 13, 27, 38). The viral proteins that have major roles in virus
entry may initiate innate immune recognition at this early stage of
the viral life cycle.
Recent studies have demonstrated that TLR9 is involved in
host responses to MCMV (24, 44), similar to responses to
some other herpesviruses, such as HSV-1 and HSV-2 (25, 27,
31). Mice deficient in TLR9 or in MyD88, an adapter molecule
that mediates TLR9 signaling, have higher splenic MCMV
titers than wild-type mice. The impaired resistance to MCMV
in these mice is associated with lower levels of the cytokines
IFN-/ and IL-12 produced by plasmacytoid dendritic cells
and decreased NK cell activity (25). The TLR3-Lps2 (TRIF)
pathway is also activated by MCMV infection (20). Mice de-
fective in TLR3 showed an increased susceptibility to MCMV
infection and diminished secretion of the cytokines IFN-/,
IL-12p40, and IFN- (44).
Studies demonstrating TLR2 activation by HCMV in vitro
(13) prompted us to ask whether TLR2 in the mouse would
play a role in regulating MCMV infection. We show here that
in addition to the recently reported roles of TLR9 and TLR3,
TLR2 activation also makes a significant contribution to the
control of MCMV infection in a manner dependent on NK
cells.
MATERIALS AND METHODS
Mice and virus infection. Mice deficient in TLR2 or TLR4 were the gift of
Shizuo Akira and were generated by gene targeting (46, 47). The TLR2 knockout
(KO) mice were completely backcrossed (F11) onto the C57BL/6 background.
C57BL/6 control mice were purchased from the Jackson Laboratories. All mice
were housed in the Department of Animal Medicine of the University of
Massachusetts Medical School under specific-pathogen-free conditions in micro-
isolator cages. The age- and sex-matched groups of mice were used between 8
and 16 weeks of age. High-titer salivary gland stocks of the MCMV Smith strain
(107 PFU/ml) were diluted in phosphate-buffered saline and were given intra-
peritoneally at 2  104 to 5  105 PFU/mouse.
In vivo NK cell depletion. One day before infection, mice were injected
intraperitoneally with 100 l of a previously determined optimal dilution of a
monoclonal antibody (MAb) specific for NK1.1. On day 4 postinfection, the
percentage of NK1.1 cells in the spleens was below 0.08% in the anti-NK1.1-
treated groups.
Virus titration. Organs (spleen, lung, and liver) harvested from infected mice
were homogenized in DMEM-5% fetal calf serum, and the MCMV titers of the
organ homogenates were determined by plaque assay on mouse embryo fibro-
blasts). Student’s t test was used for the statistical analysis of the data.
FACS analysis of spleen and liver leukocytes. Leukocytes were isolated from
the spleen by homogenizing the organ between frosted surfaces of glass micro-
scope slides, followed by lysis of the erythrocytes with 0.84% NH4Cl. One million
spleen cells per sample were stained with the appropriate surface antibodies, as
described previously, and were analyzed by fluorescence-activated cell sorter
(FACS) Cellquest Software (San Diego, CA). The antibodies used for analyses
were specific for murine CD3 and NK1.1 and were purchased from BD Bio-
sciences Pharmingen (San Diego, CA). Liver leukocytes were isolated by flushing
the blood out of the organ by injecting medium through the portal vein and then
homogenizing the liver tissue and digesting it with type II collagenase and DNase
I (both from Sigma-Aldrich) for 35 min at 37°C (32). This step was followed by
isolation of the liver leukocytes on a metrizamide density gradient.
Cytokine measurements. Bioassays for IFN-/ were performed by culturing
3  104 NCTC929 cells/well overnight in 96-well flat-bottom plates in the pres-
ence of twofold dilutions of the samples (in duplicate), followed by infection with
2  105 PFU/well vesicular stomatitis virus (VSV) strain Indiana. The assay was
evaluated 2 days postinfection, and the highest sample dilutions which protected
the NCTC929 cells from VSV-induced cytopathic effects were noted. The ex-
periment was also performed with twofold dilutions of recombinant human
IFN- (“universal type I interferon”; PBL Biomedical Laboratories, Piscataway,
NJ), and the IFN-/ titers in the samples were expressed as U/ml based on the
standard curve obtained with this recombinant type I IFN. A mixture (1:1) of
neutralizing antibodies directed against both mouse IFN- and IFN- (Calbio-
chem-Novabiochem, San Diego, CA) prevented the protective effect of the
samples on VSV-infected cells, confirming that the assayed activity was due to
IFN-/ in the samples. IL-18, IL-12p40, and IL-12p70 enzyme-linked immu-
nosorbent assays (ELISAs) were done using BD Pharmingen OptEIA (San
Diego, CA) kits. Student’s t test was used for statistical analysis.
Histopathology. Liver tissues harvested from infected mice were fixed in buff-
ered formalin, embedded in paraffin, sectioned, stained in standard hematoxylin
and eosin (HE), and evaluated for pathological changes. The inflammatory foci
were counted under a microscope at low magnification.
RESULTS
MCMV replicates to higher titers in the spleens and livers
of TLR2-deficient mice. To test whether TLR2 was involved in
early antiviral responses in vivo, we compared viral titers in
organs of MCMV-infected normal C57BL/6 mice and in their
TLR2-deficient counterparts. The mice were infected with 2 
104 PFU MCMV intraperitoneally, and their spleens, livers,
and lungs were harvested at different time points postinfection.
The viral load was determined by plaque assay of the organ
homogenates and expressed as log10 PFU/organ. We consis-
tently found that on day 4 postinfection, spleen and liver titers
of TLR2 KO mice were significantly (approximately 10-fold)
higher than those of wild-type C57BL/6 mice, whereas lung
titers were not different. Results from one representative of
three experiments are shown in Fig. 1A.
Depletion of NK cells in vivo with the MAb specific for
NK1.1 resulted in a dramatic increase in virus titers in the
spleens and livers of C57BL/6 mice. The NK cell depletion of
TLR2 KO mice, however, did not lead to a statistically signif-
icant increase in virus titers, and both NK cell-depleted and
untreated TLR2 KO mice had spleen and liver MCMV titers
as high as those of NK cell-depleted C57BL/6 mice (Fig. 1B).
These results suggested that the effect of TLR2 activation on
MCMV clearance may be NK cell mediated. Unlike TLR2 KO
mice, TLR4 KO mice did not have elevated virus titers in the
spleens and livers compared to their wild-type counterparts
(Fig. 1C).
Both C57BL/6 and TLR2 KO mice had small foci of inflam-
matory infiltrates in the liver, characteristic of MCMV infec-
tion. TLR2 KO mice, however, had a much higher number of
these infiltrates than C57BL/6 mice (Fig. 2). Thus, more severe
pathological changes were associated with the higher virus
loads in the livers of TLR2 KO mice.
MCMV-infected TLR2 KO mice have fewer NK cells in the
spleen and liver than normal mice. We asked whether the
10-fold-higher MCMV load in the spleens of TLR2-deficient
mice was due to a diminished NK cell population in the organ.
In uninfected mice, and in mice at the onset of infection, when
the number of NK cells transiently decreases in the spleen (day
1.5), there were no significant differences between wild-type
C57BL/6 and TLR2 KO mice in the size of the splenic NK cell
population (Fig. 3 A). On day 4 postinfection, however, we
found a significantly lower number of NK1.1 CD3 cells in
TLR2 KO mice than in normal C57BL/6 mice (Fig. 3B and C).
Leukocytes isolated on day 4 postinfection from livers of four
C57BL/6 and four TLR2 KO mice were pooled and analyzed
by FACS. We found a lower percentage of NK1.1 CD3 NK
cells in the livers of TLR2 KO mice than in their wild-type
C57BL/6 counterparts (data from one representative of three
experiments are shown in Fig. 3C). By day 8, although the
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percentage of NK cells in the liver remained lower in the TLR2
KO mice, no statistically significant difference in the NK cell
numbers was seen in the spleens (Fig. 3D).
The antiviral effects of NK cells are primarily mediated by
two distinct mechanisms, the secretion of IFN- and direct
granule-mediated cytotoxicity, as indicated by perforin depen-
dence (49). We examined whether NK cells in the spleens of
TLR2 KO mice differ in these functions from those of C57BL/6
mice by using intracellular staining of CD3 NK1.1 spleen
cells with a MAb specific for IFN-, and in another experiment
with granzyme B, but we found no differences in the numbers
of positively staining NK cells in the spleens of the two groups
(data not shown).
MCMV-infected TLR2 KOmice have reduced levels of IL-18
and IFN-/. Cytokines, such as IL-18 and IFN-/, have
crucial roles in the activation of NK cell responses (7, 14) and
in the regulation of the size of the activated NK cell population
following MCMV infection. The production of IL-18 and IFN-
/ exhibits a sharp peak on day 1.5 postinfection (37, 34).
Thus, we asked whether there were major differences in the
levels of these cytokines at this time point in the spleens and
livers of MCMV-infected TLR2 KO mice and wild-type C57BL/6
FIG. 1. MCMV titers in organs of wild-type C57BL/6 and TLR2
KO mice. (A) Viral titers in spleens, lungs, and livers of C57BL/6 and
TLR2 KO mice on day 4 postinfection, determined by plaque assay.
Four or five mice per group were infected with 2  104 PFU MCMV.
The asterisks indicate statistically significant differences. The P values
were determined by Student’s t test. (B) Viral titers in wild-type and
TLR2 KO mice after in vivo NK cell depletion. Mice were infected
with 5  105 PFU MCMV intraperitoneally. NK cell depletions were
performed on the day before infection in the indicated groups. The
plaque assays were performed with homogenates of organs harvested
on day 4 postinfection. The limit of detection of the plaque assays was
20 plaques per organ (log 1.3) in the spleens and 200 plaques per organ
(log 2.3) in the livers. Three or four mice per group were tested.
(C) Comparison of spleen titers of MCMV in wild-type, TLR2 KO,
and TLR4 KO mice (on identical B6-backbred backgrounds). The
mice were infected with 2 104 PFU MCMV intraperitoneally, and six
mice per group were tested. The asterisk indicates statistically signif-
icant differences between wild-type and TLR2 KO mice. The horizon-
tal lines indicate the mean values.
FIG. 2. MCMV-induced liver pathology in C57BL/6 and TLR2
KO mice. (A) Increased numbers of inflammatory foci in HE-
stained liver sections of MCMV-infected TLR2 KO mice on day 3
postinfection. The foci were counted under a microscope using low
magnification (40) by evaluating two fields per liver sample (five
or six mice per group). The error bars indicate standard deviations.
(B) Liver pathology on day 4 following MCMV infection in TLR2
KO mice. An HE-stained tissue section is shown at 100 magnifi-
cation; the arrows point to the inflammatory foci, and the arrow-
head indicates a necrotic area.
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mice. ELISAs demonstrated a significantly lower concentration
of IL-18 in TLR2 KO mice in the spleen, as well as in the liver
(Fig. 4A). A crucial role for IL-18 in the expansion of the NK cell
population controlling MCMV in the spleen was demonstrated
previously (3). The levels of IFN-/ in the spleen, determined by
bioassays in several independent experiments, were consistently
found to be decreased by approximately 50% in TLR2 KO mice
compared to wild-type mice on day 1.5 postinfection (Fig. 4B).
DISCUSSION
The major finding of this study was that in TLR2 KO mice
the early control of MCMV replication is impaired, as elevated
virus titers were found on day 4 in the spleen and in the liver.
The early control of this virus is, at least in part, due to NK
cells. It was shown previously that in vivo, NK cell depletion led
to a dramatic increase in virus titers in the spleens and livers
but had little effect on day 3 lung virus titers in C7BL/6 mice
infected intraperitoneally (11). Our findings that spleen and
liver, but not lung, virus titers were elevated in TLR2 KO mice
and that NK cell depletion eliminated the differences in virus
clearance between wild-type and TLR2 KO mice suggest that
the effect of TLR2 on MCMV clearance is NK cell mediated.
Consistent with this notion, on day 4 postinfection, the spleens
and livers of TLR2 KO mice had largely diminished NK cell
populations in comparison to infected C57BL/6 controls. It is
known that after MCMV infection, the number of splenic NK
cells decreases on day 2, due to apoptotic death (16) and
migration to the liver (40). By days 4 and 5, however, the NK
cell numbers recover in C57BL/6 mice and exceed the numbers
seen in uninfected mice. This is particularly true for Ly49H
NK cells (16). The rapid expansion of the NK cell population
in the spleen is governed by cytokines. Our results suggest that
in TLR2 KO mice, this recovery phase may be impaired after
the initial decrease in the NK cell population on day 2. This
may be caused by lack of proliferation of the NK cell popula-
tion in the spleen, which could occur because of reduced levels
of cytokines in the TLR2 KO mice. Alternatively, NK cell
migration to the spleen could be diminished or the NK cells
may be more sensitive to apoptotic death.
Recently, CD11chi CD8 DC were shown to be important
in the expansion of the NK cell population in the spleens of
FIG. 3. NK cell populations in the spleens and livers of MCMV-
infected C57BL/6 mice and TLR2 KO mice. (A) Numbers of NK1.1
CD3 NK cells in the spleen leukocyte populations of wild-type and
TLR2 KO mice on day 1.5 postinfection. Four mice per group were
infected with 2  104 PFU MCMV. The error bars indicate standard
deviations. (B) Experiment 1: numbers of NK1.1 CD3 NK cells in
the spleens of wild-type and TLR2 KO mice on day 4 postinfection.
The asterisk indicates a statistically significant difference. (C) Experi-
ment 2: numbers and percentages of NK1.1 CD3 NK cells in the
spleens and livers on day 4. The percentage in the liver was determined
using pooled cells obtained from four livers per group. (D) Numbers
and percentages of NK1.1 CD3 NK cells in the spleens and livers on
day 8.
FIG. 4. Cytokine levels in the spleens of MCMV-infected wild-type
and TLR2-deficient mice. (A) IL-18 concentrations in organ extracts
harvested on day 1.5 postinfection and determined by ELISAs. Four
mice per group were tested. (B) IFN-/ concentrations determined
by bioassays of organ extracts harvested on day 1.5 postinfection (n 
4/group). Student’s t test was used to calculate P values. The asterisk
indicates statistical significance. The error bars indicate standard de-
viations. The horizontal bars indicate the mean values.
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MCMV-infected mice (3). The survival of these CD11chi CD8
DC, in turn, was dependent on the presence of Ly49H NK cells.
It is not clear how Ly49H NK cells contribute to the mainte-
nance of the DC, but the low virus titer in mice with Ly49H NK
cells may be an important factor. The effect of the CD11chi
CD8 DC on the increase in Ly49H NK cell numbers,
however, was shown to be mediated mostly by IL-18. In IL-18
KO mice, there was no increase in Ly49H NK cells in the
spleen on day 6 of MCMV infection (3). Our finding that
spleen and liver extracts of MCMV-infected TLR2 KO mice
have lower IL-18 concentrations than those of wild-type mice
suggests that TLR2 activation by MCMV may be involved in
the induction of IL-18 in vivo. Thus, a decrease in IL-18 and,
subsequently, the lack of increase in NK cell numbers may be
key factors in the early defect of MCMV clearance in the
spleens of MCMV-infected TLR2 KO mice.
The fact that in TLR2 KO mice there was no decrease in the
percentage of IFN--secreting NK cells in response to MCMV
despite diminished IL-18 levels in the spleens and livers of
these mice seems to contradict previous reports of defective
IFN- responses in MCMV-infected IL-18 KO mice. In our
studies, however, TLR2 KO mice had low, but still detectable,
IL-18 concentrations; they did not completely lack IL-18, and
we speculate that the IL-18 levels in these mice may have been
sufficient to allow the induction of normal IFN- production.
Indeed, a potent synergism of low levels of IL-18 with IL-12 in
IFN- induction is suggested by a report by Kanakaraj et al.
(23). IL-12 levels were not significantly different in MCMV-
infected B6 and TLR2 KO mice (data not shown).
IFN-/ has long been known to enhance NK cell cytotox-
icity and, by induction of IL-15, NK cell proliferation in virus-
infected mice (8, 50). Thus, the decreased IFN-/ levels in
TLR2 KO mice may also contribute to the difference in NK
cell numbers between TLR2 KO and wild-type mice. The in-
duction of IFN-/ is regulated by several TLRs using diverse
mechanisms. TLR3 induces type I IFN via TRIF- and IRF3-
mediated pathways; TLR 7, 8, and 9 uses MyD88 and IRF7;
and TLR4 can use both of these pathways (21). The decreased
IFN-/ secretion in TLR2 KO mice following MCMV infec-
tion, and also a previous report of TLR2-dependent induction
of type I IFN in LCMV-infected mice (52), suggests the exis-
tence of a still-uncharacterized pathway linking TLR2 and
IFN-/ induction.
In this report, TLR2-deficient mice completely backcrossed
onto the C57BL/6 background had elevated MCMV titers in
both their spleens and livers. We have also extensively studied
the impact of TLR2 deficiency in TLR2 KO mice partially
backcrossed onto the C57BL/6 background. Mice were screened
for NK1.1 and Ly49H expression and compared to similarly back-
crossed 129C57BL/6 wild-type mice. In these mice with mixed
backgrounds, TLR2 deficiency was associated with enhanced
MCMV titers in the spleen, but not in the liver, and decreased
granzyme B, but normal IFN- expression in the NK cells.
Previous studies performed with partially backcrossed (129 
C57BL/6) perforin KO or IFN--deficient mice indicated that,
in the control of MCMV, IFN- is of greater significance in the
liver and perforin is of greater significance in the spleen (49).
Subsequently, however, a profound impact of perforin defi-
ciency on both spleen and liver MCMV titers was reported in
mice with a C57BL/6 background (30), and these results were
also confirmed in our laboratory. Taken together, these obser-
vations suggest the presence of an undefined additional genetic
factor contributing to organ-specific distinctions in antiviral
clearance between 129 and C57BL/6 mice.
Recent publications (33–35) have reported a role for TLR9
and TLR3 in the early control of MCMV. TLR9 and the TLR3
defects were both manifested in decreased serum concentra-
tions of IFN-/, low IFN- production by spleen NK cells,
elevated MCMV titers in the spleen, and increased mortality.
TLR3 signaling is thought to be mediated by TRIF, whereas
TLR9 signals go through the MyD88 adapter molecule. The
virus titers, however, were higher in mice deficient in MyD88
than in TLR9 KO mice in studies using both moderate-dose
(25) and high-dose (44) infection, suggesting that an additional
TLR(s) signaling through MyD88 may be involved in the con-
trol of MCMV. TLR2, shown here to participate in the early
control of MCMV, also signals through MyD88, and we also
found that MyD88 KO mice had higher virus titers than TLR2
KO mice (data not shown). Taken together, these data suggest
that MyD88 KO mice exhibit the combined effects of deficien-
cies in several TLRs on host responses to MCMV infection.
Recently, a number of viral proteins have been reported to
activate TLRs. For example, the RSV F protein and MMTV
Env activate TLR4 (12, 18, 26), and measles virus H protein,
HCMV, and HSV-1 virions activate TLR2 (6, 13, 27). In ad-
dition to viral proteins, sequences of the HSV-1 genome have
also been reported to act as ligands for TLR9 (31). Double-
stranded RNA, generated by many virus infections, is recog-
nized by TLR3 (2); single-stranded RNA oligonucleotides of
human immunodeficiency virus were found to activate TLR7
and TLR8 (19); and the single-stranded influenza virus RNA
genome was found to be recognized by TLR7. The effect of
TLR signaling on viral pathogenesis in vivo has been addressed
in a few studies. In RSV infection, TLR4 deficiency caused
delayed virus clearance, associated with a smaller population
of NK cells, macrophages, and monocytes in the lungs; de-
creased IL-12 secretion; and impaired NK cell-mediated cyto-
toxicity (18). In HSV-1 infection, the lack of TLR2 enhanced
survival due to diminished inflammatory-cytokine secretion in
the central nervous system (27). TLR4 signaling in MMTV
infection was also disadvantageous for the host by causing
IL-10 secretion, which suppressed cytotoxic-T-lymphocyte re-
sponses to virus-induced tumors (22). Thus, in different virus
infections, completely different scenarios emerge as to how
TLR signaling affects viral clearance and responses causing
protection and/or immunopathology. Infection with MCMV
(as well as some other virus infections) may activate several
TLRs that detect a variety of molecular signatures character-
istic of the infection. The simultaneous activation of a partic-
ular combination of TLRs may coordinate responses that are
most appropriate for the infecting pathogen.
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